Back to company

Pharma Components ApS: Financial statements 2020

CVR: 39103079

Pharma Components ApS (CVR 39103079) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -17,308 and a net result of DKK -15,388 compared with DKK 34,882 the year before. Equity amounted to DKK 15,120. The solvency ratio was 18.7%.

Gross Profit
-17,308 kr.
Profit/Loss
-15,388 kr.
Equity
15,120 kr.
Total Assets
80,851 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--17 t.-15 t.15 t.0
2019-45 t.35 t.31 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharma Components ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Pharma Components IVS changes name to Pharma Components ApSNov 13, 2020

On November 13, 2020, the company changed its name from Pharma Components IVS to Pharma Components ApS.

Pharma Components ApS: The 2019 annual report is outJul 1, 2020

Pharma Components ApS has published its annual report for 2019. Gross profit came to DKK 45,332, and the net result was DKK 34,882.

About Pharma Components ApS

Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity amounted to DKK 272,393.

Other financial years